When it came to medication use, CHD patients were more likely to be prescribed antiplatelet agents, oral anticoagulants, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), calcium channel blockers, oral iron, and loop diuretics than those in the control group (p < 0.05). Here, ACE is linked to coronary artery disorder.